Publications by authors named "Daniel J Crona"

23Publications

The future of research into genetics and the precision dosing of tacrolimus: what do we need to know?

Pharmacogenomics 2020 Oct 8;21(15):1061-1064. Epub 2020 Sep 8.

Division of Pharmacotherapy & Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC 27599, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/pgs-2020-0093DOI Listing
October 2020

Pharmacokinetic and pharmacodynamic analyses of cocaine and its metabolites in behaviorally divergent inbred mouse strains.

Genes Brain Behav 2020 May 8:e12666. Epub 2020 May 8.

Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/gbb.12666DOI Listing
May 2020

Projected impact of pharmacogenomic testing on medications beyond antiplatelet therapy in percutaneous coronary intervention patients.

Pharmacogenomics 2020 05 28;21(7):431-441. Epub 2020 Apr 28.

Division of Pharmacotherapy & Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/pgs-2019-0185DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252508PMC
May 2020

Targeting an EGFR Water Network with 4-Anilinoquin(az)oline Inhibitors for Chordoma.

ChemMedChem 2019 10 23;14(19):1693-1700. Epub 2019 Sep 23.

Structural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, 27599, USA.

View Article

Download full-text PDF

Source
https://onlinelibrary.wiley.com/doi/abs/10.1002/cmdc.2019004
Publisher Site
http://dx.doi.org/10.1002/cmdc.201900428DOI Listing
October 2019

Anti-tubercular activity of novel 4-anilinoquinolines and 4-anilinoquinazolines.

Bioorg Med Chem Lett 2019 09 10;29(18):2695-2699. Epub 2019 Jul 10.

Structural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2019.07.012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6736633PMC
September 2019

Current practices in the delivery of pharmacogenomics: Impact of the recommendations of the Pharmacy Practice Model Summit.

Am J Health Syst Pharm 2019 Apr;76(8):521-529

Mayo Clinic College of Medicine, Hospital Pharmacy Services, Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ajhp/zxz024DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6480071PMC
April 2019

Direct oral anticoagulants in extremely obese patients: OK to use?

Res Pract Thromb Haemost 2019 Apr 24;3(2):152-155. Epub 2018 Dec 24.

Division of Hematology-Oncology Department of Medicine Northwestern University Chicago Illinois.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/rth2.12178DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6462739PMC
April 2019

SGC-GAK-1: A Chemical Probe for Cyclin G Associated Kinase (GAK).

J Med Chem 2019 03 26;62(5):2830-2836. Epub 2019 Feb 26.

Structural Genomics Consortium, Johann Wolfgang Goethe University, Buchmann Institute for Molecular Life Sciences, Max-von-Laue-Straße 15 , D-60438 Frankfurt am Main , Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/acs.jmedchem.8b01213DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6567991PMC
March 2019

Recurrent venous thromboembolism in primary membranous nephropathy despite direct Xa inhibitor therapy.

J Nephrol 2019 Aug 12;32(4):669-672. Epub 2018 Nov 12.

Division of Nephrology and Hypertension, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s40620-018-0552-9
Publisher Site
http://dx.doi.org/10.1007/s40620-018-0552-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6511492PMC
August 2019

Genetic Variants of and Are Determinants of Survival in Renal Cell Carcinoma Patients Treated with Sorafenib.

Cancer Res 2019 01 1;79(1):231-241. Epub 2018 Nov 1.

Division of Pharmacotherapy and Experimental Therapeutics, Center for Pharmacogenomics and Individualized Therapy, The University of North Carolina Eshelman School of Pharmacy, Chapel Hill, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-18-1089DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6541205PMC
January 2019

Infusion reactions following administration of intravenous rolapitant at an academic medical center.

J Oncol Pharm Pract 2019 Oct 22;25(7):1776-1783. Epub 2018 Oct 22.

1 Department of Pharmacy, University of North Carolina Hospitals and Clinics, Chapel Hill, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1078155218808084DOI Listing
October 2019

Cabozantinib-induced serum creatine kinase elevation and musculoskeletal complaints.

Invest New Drugs 2018 12 28;36(6):1143-1146. Epub 2018 Jun 28.

Department of Pharmacy, University of North Carolina Medical Center, Chapel Hill, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-018-0629-2DOI Listing
December 2018

Precision Dosing: Public Health Need, Proposed Framework, and Anticipated Impact.

Clin Transl Sci 2017 11 10;10(6):443-454. Epub 2017 Aug 10.

Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/cts.12490DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5698804PMC
November 2017

Androgen Receptor-Dependent and -Independent Mechanisms Involved in Prostate Cancer Therapy Resistance.

Cancers (Basel) 2017 Jun 12;9(6). Epub 2017 Jun 12.

Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers9060067DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5483886PMC
June 2017

A Systematic Review of Strategies to Prevent Cisplatin-Induced Nephrotoxicity.

Oncologist 2017 05 24;22(5):609-619. Epub 2017 Apr 24.

Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2016-0319DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5423518PMC
May 2017

Application of liquid biopsies to identify genomic factors associated with therapy resistance in castration resistant prostate cancer.

Ann Transl Med 2016 Oct;4(Suppl 1):S64

Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, USA;; Division of Hematology and Oncology, Department of Medicine, School of Medicine, University of North Carolina, Chapel Hill, North Carolina, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/atm.2016.10.39DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5104657PMC
October 2016

Phase 1/2 multiple ascending dose trial of the prostate-specific membrane antigen-targeted antibody drug conjugate MLN2704 in metastatic castration-resistant prostate cancer.

Urol Oncol 2016 12 17;34(12):530.e15-530.e21. Epub 2016 Oct 17.

Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; Department of Medicine, Weill Cornell Medical College, New York, NY. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2016.07.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5464417PMC
December 2016

Posterior reversible encephalopathy syndrome induced by enzalutamide in a patient with castration-resistant prostate cancer.

Invest New Drugs 2015 Jun 3;33(3):751-4. Epub 2014 Dec 3.

Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10637-014-0193-3
Publisher Site
http://dx.doi.org/10.1007/s10637-014-0193-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4451215PMC
June 2015

The Value of Pharmacy Residency Training for Health Systems: An Annotated Bibliography.

J Pharm Pract 2014 Aug 20;27(4):399-411. Epub 2014 Mar 20.

Division of Pharmacy Practice & Administration, School of Pharmacy, University of Missouri Kansas City, Kansas City, MO, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0897190013515707DOI Listing
August 2014

Regorafenib: a novel multitargeted tyrosine kinase inhibitor for colorectal cancer and gastrointestinal stromal tumors.

Ann Pharmacother 2013 Dec 1;47(12):1685-96. Epub 2013 Nov 1.

University of North Carolina (UNC) Eshelman School of Pharmacy, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1060028013509792DOI Listing
December 2013